What's new

Human medicines European public assessment report (EPAR): Siiltibcy, Mycobacterium tuberculosis derived antigens (rdESAT-6 / rCFP-10), Date of authorisation: 13/01/2025, Status: Authorised

Human medicines European public assessment report (EPAR): Siiltibcy, Mycobacterium tuberculosis derived antigens (rdESAT-6 / rCFP-10), Date of authorisation: 13/01/2025, Status: Authorised

Feb 19, 2025 - 11:39
 0
Human medicines European public assessment report (EPAR): Siiltibcy, Mycobacterium tuberculosis derived antigens (rdESAT-6 / rCFP-10), Date of authorisation: 13/01/2025, Status: Authorised
Human medicines European public assessment report (EPAR): Siiltibcy, Mycobacterium tuberculosis derived antigens (rdESAT-6 / rCFP-10), Date of authorisation: 13/01/2025, Status: Authorised
Read More

Tags:

Previous Article

Asda updates on 2024 Gender Pay

Next Article

Superdrug announces official charity partner across the Republic of Ireland

Related Posts

Human medicines European public assessment report (EPAR): Erbitux, cetuximab, Date of authorisation: 29/06/2004, Revision: 33, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 19, 2025  0

Recommendations on eligibility to PRIME scheme - Adopte...

Feb 9, 2025  0

Human medicines European public assessment report (EPAR): Apretude, cabotegravir, Date of authorisation: 15/09/2023, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 19, 2025  0